ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

2018 Quality Payment Program Rule Highlights

November 13, 2017
By Blair Burnett, <em>ACCC Policy Analyst</em>

2018 Quality Payment Program Rule Highlights

On Thursday, Nov. 2, 2017, the Centers for Medicare & Medicaid Services released the 2018 final rule for the second year of the Medicare Access & CHIP Reauthorization Act (MACRA) Quality Payment Program (QPP). While we were disappointed by some policies in the 2018 rule, in general, the final rule signals a continued commitment to increased flexibility and reduced administrative burden for clinicians.

Starting in 2019, Medicare-participating clinicians will have to choose whether they will participate in the new QPP through one of two tracks: the fee-for-service based Merit-Based Incentive Payment System (MIPS) or through an Advanced Alternative Payment Model (APM). Clinicians should be reporting measures now (in 2017) for payment adjustments that will occur in 2019. If you are not aware of your obligations under the QPP, be sure to familiarize yourself as soon as possible – most clinicians should be reporting on three MIPS categories (quality measures, advancing care information, and clinical practice improvement activities) now for changes that are coming in 2019.

The final rule that outlines the QPP program in 2018 significantly reduces the number of providers subject to scoring under the MIPS track of the QPP. In 2018, any clinician with less than $90,000 in Medicare Part B allowed charges or fewer than 200 Part B beneficiaries will be exempt from MIPS reporting (previously this “low-volume threshold” was $30,000 in Part B charges and 100 Part B patients). With these changes, it is estimated that 123,000 providers will be excluded from MIPS scoring. CMS is also expanding access to reporting under the Advanced Alternative Payment Model (APM) track of the QPP. Clinicians who are participating in the Medicare Shared Savings Program (MSSP) Track 1+ as well as the Next Generation ACO Model and the Comprehensive Primary Care Plus (CPC+) program will all now qualify for QPP reporting as an advanced APM. CMS estimates that about 185,000 to 250,000 clinicians will now be eligible for reporting under an advanced APM, creating more competition within the MIPS track. CMS also expanded the option of reporting as virtual groups for physicians in groups of 10 or fewer and added bonus opportunities for small practices and clinicians treating complex patients.

CMS also eases reporting requirements around electronic health record (EHR) use, allowing MIPS-eligible physicians to be able to use 2014 or 2015 editions of certified EHR technology to meet the Advancing Care Information (ACI) category. Additionally, clinicians across the U.S. who were significantly affected by Hurricanes Harvey, Irma, and/or Maria are eligible to apply for an ACI hardship exception. These affected clinicians are eligible to apply for reweighting of the MIPS reporting requirements for quality, cost, and improvement activities categories for the 2018 performance period. The deadline to apply for both exemptions is December 31, 2017.

Despite these flexibilities, ACCC is disappointed to see that CMS has moved up the timeline to hold clinicians accountable for the cost of care they provide. Originally CMS had proposed that the cost category under MIPS be weighted at zero in 2018, however the final rule requires that cost account for 10% of the MIPS score in 2018. Additionally, despite opposition from ACCC and many stakeholders, CMS also finalized that Part B drug revenue will be subject to the MIPS adjustment, which is not what we believe Congress intended and breaks from past precedent in CMS policies.

We expect QPP participation and requirements will continue to evolve in the coming years, but be sure to prepare yourself now – these changes to Medicare reimbursement are around the corner.

ACCC members are invited to join us for a webinar on Wednesday, December 6, 2017, from 3-4 PM EST, for an in-depth analysis of the CY 2018 QPP final rule and how these changes may impact providers and their cancer program or practice. Learn more and register (log in required).

Related Content

Extending Patient-Centered Cancer Care to Transgender and Nonbinary IndividualsACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Gabrielle Stearns

June 30, 2026

Transforming Oncology Authorization Through Clinical and Revenue Cycle CollaborationACCCBuzz Blog

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Rachel Radwan

June 29, 2026

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

MDS: Low Risk Isn’t No Risk - [Podcast] Ep. 239

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login